Holdings (Monthly)
Guide ↗
Eaton Vance Worldwide Health Sciences Fund
· Eaton Vance Growth Trust| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | 532457108 | Feb 2026 | 92,406 | $97.2M | 11.33% | EC |
| 2 | AbbVie Inc | 00287Y109 | Feb 2026 | 246,272 | $57.2M | 6.66% | EC |
| 3 | AstraZeneca PLC | 000000000 | Feb 2026 | 266,858 | $56.2M | 6.54% | EC |
| 4 | Johnson & Johnson | 478160104 | Feb 2026 | 216,808 | $53.9M | 6.28% | EC |
| 5 | Roche Holding AG | 000000000 | Feb 2026 | 105,518 | $50.2M | 5.85% | EC |
| 6 | Merck & Co Inc | 58933Y105 | Feb 2026 | 307,185 | $38.0M | 4.43% | EC |
| 7 | Bristol-Myers Squibb Co | 110122108 | Feb 2026 | 563,654 | $35.2M | 4.10% | EC |
| 8 | UnitedHealth Group Inc | 91324P102 | Feb 2026 | 109,349 | $32.1M | 3.74% | EC |
| 9 | Vertex Pharmaceuticals Inc | 92532F100 | Feb 2026 | 60,680 | $30.1M | 3.51% | EC |
| 10 | Gilead Sciences Inc | 375558103 | Feb 2026 | 188,375 | $28.1M | 3.27% | EC |
| 11 | Abbott Laboratories | 002824100 | Feb 2026 | 236,553 | $27.5M | 3.21% | EC |
| 12 | Zoetis Inc | 98978V103 | Feb 2026 | 200,609 | $26.3M | 3.07% | EC |
| 13 | Sanofi SA | 000000000 | Feb 2026 | 254,833 | $24.9M | 2.90% | EC |
| 14 | Thermo Fisher Scientific Inc | 883556102 | Feb 2026 | 47,190 | $24.6M | 2.87% | EC |
| 15 | Intuitive Surgical Inc | 46120E602 | Feb 2026 | 48,480 | $24.4M | 2.84% | EC |
| 16 | Boston Scientific Corp | 101137107 | Feb 2026 | 294,341 | $22.6M | 2.64% | EC |
| 17 | Stryker Corp | 863667101 | Feb 2026 | 54,948 | $21.3M | 2.48% | EC |
| 18 | Medtronic PLC | 000000000 | Feb 2026 | 185,134 | $18.1M | 2.11% | EC |
| 19 | Lonza Group AG | 000000000 | Feb 2026 | 21,984 | $15.3M | 1.78% | EC |
| 20 | CSL Ltd | 000000000 | Feb 2026 | 134,162 | $14.0M | 1.64% | EC |
| 21 | Argenx SE | 04016X101 | Feb 2026 | 17,543 | $13.5M | 1.57% | EC |
| 22 | Edwards Lifesciences Corp | 28176E108 | Feb 2026 | 146,286 | $12.6M | 1.47% | EC |
| 23 | Mettler-Toledo International Inc | 592688105 | Feb 2026 | 8,731 | $11.9M | 1.39% | EC |
| 24 | Novartis AG | 000000000 | Feb 2026 | 70,029 | $11.8M | 1.37% | EC |
| 25 | Cooper Cos Inc/The | 216648501 | Feb 2026 | 128,221 | $10.7M | 1.25% | EC |
| 26 | Novo Nordisk A/S | 000000000 | Feb 2026 | 283,516 | $10.7M | 1.25% | EC |
| 27 | Straumann Holding AG | 000000000 | Feb 2026 | 83,976 | $10.1M | 1.17% | EC |
| 28 | Royalty Pharma PLC | 000000000 | Feb 2026 | 215,358 | $10.0M | 1.16% | EC |
| 29 | Danaher Corp | 235851102 | Feb 2026 | 37,052 | $7.8M | 0.91% | EC |
| 30 | Neurocrine Biosciences Inc | 64125C109 | Feb 2026 | 51,654 | $6.8M | 0.80% | EC |
| 31 | McKesson Corp | 58155Q103 | Feb 2026 | 6,322 | $6.2M | 0.73% | EC |
| 32 | Bio-Techne Corp | 09073M104 | Feb 2026 | 100,598 | $5.9M | 0.69% | EC |
| 33 | Option Care Health Inc | 68404L201 | Feb 2026 | 178,995 | $5.8M | 0.68% | EC |
| 34 | Recordati Industria Chimica e Farmaceutica SpA | 000000000 | Feb 2026 | 91,672 | $5.2M | 0.61% | EC |
| 35 | HeartFlow Inc | 42238D107 | Feb 2026 | 218,978 | $5.1M | 0.59% | EC |
| 36 | Genmab A/S | 000000000 | Feb 2026 | 16,690 | $4.9M | 0.57% | EC |
| 37 | Amplifon SpA | 000000000 | Feb 2026 | 225,283 | $3.5M | 0.41% | EC |
| 38 | Newamsterdam Pharma Co NV | 000000000 | Feb 2026 | 81,652 | $2.9M | 0.34% | EC |
| 39 | EssilorLuxottica SA | 000000000 | Feb 2026 | 10,648 | $2.8M | 0.33% | EC |
| 40 | Caris Life Sciences Inc | 142152107 | Feb 2026 | 135,807 | $2.7M | 0.32% | EC |
| 41 | Centessa Pharmaceuticals PLC | 152309100 | Feb 2026 | 91,966 | $2.5M | 0.29% | EC |
| 42 | Apogee Therapeutics Inc | 03770N101 | Feb 2026 | 33,655 | $2.4M | 0.27% | EC |
| 43 | Xenon Pharmaceuticals Inc | 98420N105 | Feb 2026 | 51,377 | $2.2M | 0.26% | EC |
| 44 | Morgan Stanley & Co. LLC | 61747C707 | Feb 2026 | 242,780 | $243K | 0.03% | STIV |